ABSTRACT Airway responsiveness to methacholine varies between normal people and is increased in patients with asthma. The importance of airway smooth muscle sensitivity in determining in vivo responsiveness is unknown. We have examined this question by comparing in vivo airway responsiveness with in vitro airway smooth muscle sensitivity to methacholine in 10 patients undergoing thoracic surgery. In vivo responsiveness was determined by administration of inhalations of doubling concentrations of methacholine. Results were expressed as the provocation concentration (PC) causing a decrease in forced expiratory volume in one second of 20% (PC2OFEV1), specific airway conductance of 35% (PC35sGaw), and maximal expiratory flow at 35% vital capacity, measured for the partial (V35(p)) and complete (V35(C)) flow volume curves, of 35% (PC35V35(p); PC35V35(c)). In vitro airway smooth muscle sensitivity was determined from specimens obtained at thoracotomy. Log dose-response curves to methacholine were constructed and the concentration causing a 50% maximum contraction (EC50) was derived. There were differences between patients for both in vivo airway responsiveness and in vitro smooth muscle sensitivity to methacholine. There were no significant relationships between the in vivo and in vitro measurements. The results suggest that factors other than solely the sensitivity of smooth muscle must determine in vivo airway responsiveness to methacholine.
ABSTRACT Airway responsiveness to methacholine varies between normal people and is increased in patients with asthma. The importance of airway smooth muscle sensitivity in determining in vivo responsiveness is unknown. We have examined this question by comparing in vivo airway responsiveness with in vitro airway smooth muscle sensitivity to methacholine in 10 patients undergoing thoracic surgery. In vivo responsiveness was determined by administration of inhalations of doubling concentrations of methacholine. Results were expressed as the provocation concentration (PC) causing a decrease in forced expiratory volume in one second of 20% (PC2OFEV1), specific airway conductance of 35% (PC35sGaw), and maximal expiratory flow at 35% vital capacity, measured for the partial (V35(p)) and complete (V35(C)) flow volume curves, of 35% (PC35V35(p); PC35V35(c)). In vitro airway smooth muscle sensitivity was determined from specimens obtained at thoracotomy. Log dose-response curves to methacholine were constructed and the concentration causing a 50% maximum contraction (EC50) was derived. There were differences between patients for both in vivo airway responsiveness and in vitro smooth muscle sensitivity to methacholine. There were no significant relationships between the in vivo and in vitro measurements. The results suggest that factors other than solely the sensitivity of smooth muscle must determine in vivo airway responsiveness to methacholine.
Airway responsiveness to the cholinergic agonist methacholine varies between normal people' and is increased in patients with asthma.' 2 The reduction in airway calibre induced by this agonist involves the contraction of airway smooth muscle.3 Thus the difference in responsiveness to methacholine in normal and asthmatic subjects may be related to variations between individuals in their airway smooth muscle sensitivity to this agent. Alternatively, the variability between subjects in responsiveness may be a consequence of differences in the neural or humoral control (or both) of airway smooth muscle. Previous studies have found that in vitro airway smooth muscle sensitivity to a cholinergic agonist varies between individuals,345 but the in vitro values were not related to in vivo measurements of responsiveness.
In this study we have compared in vivo airway responsiveness to methacholine with in vitro sensitivity of preparations of isolated bronchi taken from the same patient at thoractomy, to determine whether variation in responsiveness to methacholine may be explained by differences in the sensitivity of airway smooth muscle to the drug.
Methods

PATIENTS
Ten patients scheduled to undergo lobectomy or pneumonectomy were studied ( After equilibration the tissue was exposed twice to near maximally effective concentrations of methacholine (10 ,umol/l, determined in preliminary experiments) at 30 minute intervals to gauge the magnitude, normality, and reproducibility of the contractions. A cumulative concentration-effect curve was then constructed by adding increasing concentrations of methacholine (from 10 nmol/l to 1 mmol/l) until a maximum response was obtained. Each addition of the drug was made at the peak of effect produced by the preceding concentration. In each experiment the concentrations of methacholine that produced a 20% (EC20) and 50% (EC50) maximal contraction were calculated from the graphically displayed data. Additionally, the maximum tension generated was determined and expressed in g tension. At least four bronchial strips from each patient were tested and mean values for EC20, EC,,, and maximum tension generated determined.
In preliminary experiments no significant difference was found between the sensitivity of bronchial strips taken from second and from sixth order bronchi. STATISTICAL Nevertheless, a relationship between in vivo airway responsivesness and in vitro sensitivity of more peripheral airway smooth muscle cannot be excluded from this study. In addition, the access of a bronchoconstrictor drug to airway smooth muscle, and thus the response to that drug may be affected by airway permeability.'4 But although airway permeability was found to be increased in smokers'5 no relationship was found between the level of airway permeability and airway responsiveness. '6 It is impossible to produce a full dose-response curve to a bronchoconstrictor agent in man, so the position on the in vitro curve at which in vivo responses are measured is unclear. If, for example, the in vivo measurements fell on the lower nonlinear region of the full in vitro log dose-response curve, then in vivo and in vitro measurements might not be correlated even if in vivo responsiveness was determined by smooth muscle sensitivity. We found no relationship, however, between in vivo responsiveness and a measure of in vitro sensitivity taken from the lower part of the dose-response curve (EC20). We also found no significant relationship between in vivo responsiveness to methacholine and the maximum tension generated by bronchial strips from each patient. Maximum tension may be related to the quantity of smooth muscle present in each bronchial strip which ideally should be measured but this is technically difficult. In an attempt to correct for variations in the amount of tissue and hence smooth muscle present, the maximum force generated was corrected for the wet weight of tissue in each strip. This was compared with the indices of in vivo responsiveness but no relationship was found.
This study has considered only one agonist, methacholine, which may be acting on muscarinic receptors on airway smooth muscle,3 submucosal glands,23 presynaptic receptors on sympathetic nerves,24 and mast cells. 25 The bronchoconstrictor response may therefore be due to mechanisms other than solely a direct effect on airway smooth muscle.
Patients selected for this study were due to undergo thoracic surgery. Most had bronchial carcinoma and were current smokers or ex-smokers and only one showed in vivo hyperresponsiveness, with a PC20FEV1 below 8 mg/ml.2 In these patients our findings suggest that smooth muscle sensitivity alone does not determine in vivo airway responsiveness to methacholine.
The cause of airway hyperresponsiveness in asthma is unknown. It could be due to an abnormality in airway smooth muscle or to the neural or humoral control of the airways (or both).2628 In this study only one patient had some features of asthma. Although we were able to study him only over a short period and were unable to assess the airway resonse to a "trial of steroids," he had symptoms of wheezy dyspnoea, showed a 14% increase in FEV, after bronchodilator, had Curschmann's spirals in his sputum, and had an increased response to inhaled methacholine. The airway smooth muscle strips from this patient, however, were not hypersen-'sitive to methacholine. This finding, if confirmed in other patients with definite asthma, would indicate that airway hyperresponsiveness is not attributable to an increased sensitivity to methacholine at the receptor level (as indicated by the EC,, value). In support of this finding with methacholine, Dahlen and coworkers29 recently reported that the response of bronchial strips to histamine, prostaglandin FZ,, Roberts, Raeburn, Rodger, Thomson and leukotreine D4 were similar in normal and asthmatic subjects.
Addendum
Since our original submission of this paper, Vincenc and coworkers30 have reported that they found no relationship between in vivo and in vitro responses to histamine in a group of non-asthmatic patients undergoing thoracic surgery. 
